Coronary Artery Disease Is a Predictor of Progression to Dialysis in Patients With Chronic Kidney Disease, Type 2 Diabetes Mellitus, and Anemia: An Analysis of the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)

BACKGROUND: Although clear evidence shows that chronic kidney disease is a predictor of cardiovascular events, death, and accelerated coronary artery disease (CAD) progression, it remains unknown whether CAD is a predictor of progression of chronic kidney disease to end‐stage renal disease. We sough...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabe, Marwa A., Claggett, Brian, Burdmann, Emmanuel A., Desai, Akshay S., Ivanovich, Peter, Kewalramani, Reshma, Lewis, Eldrin F., McMurray, John J. V., Olson, Kurt A., Parfrey, Patrick, Solomon, Scott D., Pfeffer, Marc A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859277/
https://www.ncbi.nlm.nih.gov/pubmed/27108247
http://dx.doi.org/10.1161/JAHA.115.002850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859277/
https://www.ncbi.nlm.nih.gov/pubmed/27108247
http://dx.doi.org/10.1161/JAHA.115.002850

Ejemplares similares